Effects of reproductive tract glutathione enhancement and depletion on ethyl methanesulfonate-induced dominant lethal mutations in Sprague-Dawley rats
| Autor: | L A Conder, H K Bates, Jay Gandy, Raymond D. Harbison |
|---|---|
| Rok vydání: | 1992 |
| Předmět: |
Male
medicine.medical_specialty Ethyl methanesulfonate Health Toxicology and Mutagenesis Mutagen Biology Genitalia Male Toxicology medicine.disease_cause Rats Sprague-Dawley chemistry.chemical_compound Internal medicine Genetics medicine Animals Genetics (clinical) Phorone Fetus Long-term potentiation Glutathione Fetal Resorption Ketones Epididymis Acetylcysteine Rats medicine.anatomical_structure Endocrinology Oncology chemistry Ethyl Methanesulfonate Toxicity Mutation Mutagens |
| Zdroj: | Teratogenesis, carcinogenesis, and mutagenesis. 12(2) |
| ISSN: | 0270-3211 |
| Popis: | The effects of altering glutathione (GSH) levels in the male reproductive tract have been studied in an attempt to establish a link between chemical-induced perturbations in glutathione and susceptibility of spermatozoa to chemical insult. Tissue GSH levels were enhanced by a treatment regimen of N-acetylcysteine (NAC) (250 mg/kg, 4 treatments at 2 h intervals). With this treatment, GSH levels in liver, testis, caput epididymis, and cauda epididymis were elevated to 126%, 110%, 178%, and 136% of control values. Sexually mature male rats were then treated with NAC and challenged with a dose of EMS (100 mg/kg) to determine if enhanced tissue GSH would protect against EMS-induced dominant lethal mutations. Pretreatment with NAC significantly decreased the post-implantation loss from 7.05 +/- 0.57 with EMS alone to 5.28 +/- 0.47. Conversely, a dominant lethal assay was conducted using different doses of phorone pretreatment to determine the relative contribution of hepatic versus reproductive tract GSH in protecting against EMS-induced dominant lethal resorptions. Doses of 100 mg/kg and 250 mg/kg phorone significantly lowered both hepatic and reproductive tract GSH while 25 mg/kg lowered only hepatic GSH. These three dose levels were used as pretreatments in a dominant lethal study followed by a challenge administration of EMS (50 mg/kg), which is a threshold dose of EMS for producing dominant lethal mutations. Comparison against controls demonstrated a significant potentiation of fetal resorptions in all groups receiving phorone pretreatment, including the 25 mg/kg pretreatment group which only lowered hepatic GSH prior to EMS challenge. The results of these experiments indicate that GSH reserves in the male reproductive tract are insufficient to protect developing spermatozoa from damage by alkylating agents in the absence of hepatic GSH. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text